FRANCISELLA TULARENSIS (a.k.a. Pasteurella tularensis)ref

Table of contents :


  • Epidemiology
  • Genomics
  • Transmission
  • Pathogenesis
  • Symptoms & signs
  • Laboratory examinations
  • Therapy
  • Prognosis
  • Prevention

  • Epidemiology : this infectious disease was first described in Japan in 1837. The name of the disease is related to 1911 description of a plague-like illness in ground squirrels in Tulare County, California, and work done by Dr. Edward Francis. Dr. Francis described his personal experience with more than 800 cases in 1928. Genomics : the complete genome sequence of a highly virulent isolate of F. tularensis (1,892,819 bp) uncovers previously uncharacterized genes encoding type IV pili, a surface polysaccharide and iron-acquisition systems. Several virulence-associated genes were located in a putative pathogenicity island, which was duplicated in the genome. > 10% of the putative coding sequences contained insertion-deletion or substitution mutations and seemed to be deteriorating. The genome is rich in IS elements, including IS630 Tc-1 mariner family transposons, which are not expected in a prokaryote. A computational method was used for predicting metabolic pathways and found an unexpectedly high proportion of disrupted pathways, explaining the fastidious nutritional requirements of the bacterium. The loss of biosynthetic pathways indicates that F. tularensis is an obligate host-dependent bacterium in its natural life cycleref
    Pathogenesis : an obligate intracellular bacterium; induces aberrant activation of pulmonary dendritic cells, which are unable to secrete cytokines in response to specific TLR agonistsref
    => tularemia / Francis-Ohara disease / deer fly fever / Pahvant Valley fever or plague / rabbit fever (a zooanthroponosis) after 3-7 days incubation :
    Transmissionref1, ref2 :
    Although the ID50 of the bacillus in the laboratory is < 100 organisms, the lung infection does not transmit from person-to-person.
    Laboratory examinations : PCR, intradermoreaction
    Therapy : the drugs of choice are streptomycin (1 g intramuscularly [IM] twice daily) or gentamicin (5 mg/kg IM or intravenously [IV] once daily). Alternatives are ciprofloxacin (400 mg IV twice daily) or the bacteriostatic drugs doxycycline (100 mg IV twice daily) or chloramphenicol (15 mg/kg IV 4 times daily). (The dosages listed are for adults.) Suggested duration of treatment is 10 days for streptomycin, gentamicin, or ciprofloxacin and 14 days for doxycycline and chloramphenicol. When clinically indicated, a change to oral therapy can be made with the latter 3 medications. It should be noted that gentamicin, chloramphenicol, and ciprofloxacin, although quite active, are not FDA-approved for the treatment of tularemia. b-lactam antimicrobials and macrolides are not recommended for treatment. For postexposure prophylaxis in the setting of biowarfare, the Working Group recommends the use of oral doxycycline (adult dosage of 100 mg orally twice daily) or ciprofloxacin (adult dosage of 500 mg orally twice daily) for 14 days.
    Prognosis : in the pre-antimicrobial era, the mortality from type A infections was between 5-15% of cases but as high as 30-60% for untreated pneumonic and typhoidal formsref
    Prevention : attenuated vaccine
    Although not generally transferable from person to person, the infectious dose of F. tularensis is quite low, and the organism is considered by CDC as a category A biological weapon

    Copyright © 2001-2005 Daniele Focosi. All rights reserved Terms of use  | Legal notices
    About this site  |  Site map  |  Acknowledgements | Open forum  |  Tell a friend about this site  |  Current link partners
     Abbreviations and acronyms  |  Medical terminology  |  Add a link  |  Translate this site into your favourite language  |  Softwares

    Rate Us:



    This website subscribes to the HONcode principles of the HON Foundation. Click to verify.
    PicoSearch
     

    Search 
    Search 
    for 
    Search Medical Dictionary 
    for